Zio XT ECG Monitoring System vs PMcardio
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT if you need extended, continuous cardiac monitoring for up to 14 days to detect infrequent or paroxysmal arrhythmias that might be missed by shorter monitoring periods. Its wearable, water-resistant design and lack of external wires promote high patient compliance and comfort during normal daily activities, making it suitable for patients who need discreet, long-term monitoring. This tool is also beneficial for reducing retesting rates and achieving a faster time to clinical diagnosis compared to other ambulatory cardiac monitors.
View Zio XT ECG Monitoring System →Choose PMcardio if…
Choose PMcardio if you require rapid, AI-powered interpretation of 12-lead ECGs at the point of care for immediate assessment of over 50 cardiac conditions, including critical STEMI/OMI detection. This tool is ideal for emergency settings, primary care, or any situation where quick, expert-level ECG analysis is crucial for confident decision-making and optimizing patient triage and care pathways.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | PMcardio |
|---|---|---|
| Pricing | Contact for pricing | Freemium |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Pending AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemZio XT offers a wearable, wire-free biosensor that patients can wear for up to 14 days, including during daily activities like showering, promoting high patient compliance and comfort. PMcardio, while accessible via mobile and web, requires users to actively scan ECGs, which may introduce more steps and potential for user error compared to the passive, continuous monitoring of Zio XT.
Clinical Value
PMcardioPMcardio boasts a broader diagnostic capability, detecting over 50 cardiac conditions and offering AI explainability with heatmaps, which can enhance clinician understanding and trust. It has also demonstrated superior accuracy in detecting acute myocardial infarction and reducing false STEMI alarms in multiple studies. While Zio XT provides high diagnostic yield for arrhythmias over extended monitoring periods, its diagnostic scope is more focused on arrhythmia detection rather than a wide range of cardiac conditions.
Pricing & Value
PMcardioPMcardio offers a freemium model with 5 free ECG analyses per month, allowing individual clinicians to try the service before committing to a paid plan. Its transparent pricing for individual and team plans is readily available. Zio XT's pricing is primarily enterprise-focused and requires direct contact for details, with Medicare rates suggesting a higher per-patient cost.
Enterprise Readiness
PMcardioPMcardio is designed for enterprise deployment, offering integrations with EHR/CVIS and EMS systems, and a unified platform for system-wide cardiac care coordination. It emphasizes a single integration and security review for health systems. Zio XT is cloud-based and HIPAA compliant, but its enterprise integration capabilities are not as explicitly detailed or as broad as PMcardio's.
Innovation
PMcardioPMcardio demonstrates strong innovation with its AI explainability feature (ECGxplainu2122) that provides visual heatmaps for diagnostic rationale, and its focus on detecting a wide array of cardiac conditions, including subtle STEMI equivalents and reduced LVEF. Zio XT's innovation lies in its extended wear time and high patient compliance for continuous arrhythmia monitoring, but its core technology is a more established form of wearable ECG.
Support & Docs
TieBoth tools provide essential documentation. Zio XT offers clinical reference manuals and instructions for use for its devices and software. PMcardio provides a help center with instructions for use for individuals and regulatory documentation. Without further specific details on the breadth and responsiveness of their support channels (e.g., 24/7 support, dedicated account managers), it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | PMcardio |
|---|---|---|
| Company | iRhythm Technologies | Powerful Medical |
| Tagline | Innovating the Future of Cardiac Monitoring: Precision Brought to Your Practice | AI that reads ECGs in seconds |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Clinical Decision Support & Reference |
| Key Feature 1 | Wearable single-lead ECG biosensor (Zio biosensor) | Instant AI-powered ECG interpretations |
| Key Feature 2 | Continuous ambulatory cardiac monitoring for up to 14 days | Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders) |
| Key Feature 3 | Water-resistant design for normal daily activities, including showering | Queen of Heartsu2122 - STEMI and OMI Detection |
| Key Feature 4 | Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis | ECGxplainu2122 - Visual AI Explainability with heatmaps |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and PMcardio.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or PMcardio
Backers
Who funded each tool's parent company.